Amino-pyrrolopyrimidinone compounds and methods of use thereof
US11020398B2 · kind B2 · utility
1Cited by
7References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2017 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Aug 23, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/341
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of BTK, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.